Skip to main content
. 2012 Mar 7;2012:389485. doi: 10.1155/2012/389485

Figure 1.

Figure 1

(a) This graph shows the global nanomedicine market size, measured in terms of revenues, such as sales revenues, grants revenues, and milestones. From 2006 to date, a steady growth has occurred, which is expected to continue through 2014, at a CAGR of 13.5% [5]. (b) The graph illustrates the market size for the anticancer applications segment. Except for a slight decrease in 2008, the market has and is predicted to expand by a factor of steady growth [5].